EICHOR
● Active Not Recruiting
Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery
Condition: Elderly · Surgery · Analgesia · Sponsor: Peking University First Hospital
About this study
A majority of the elderly patients undergo surgery for malignant tumors. For these patients, postoperative tumor recurrence and metastasis are main factors that worsen long-term outcomes. The investigators hypothesize that dexmedetomidine supplemented analgesia in elderly patients after cancer surgery may help to maintain immune function and improve long-term outcomes, possibly by relieving stress and inflammatory response, improving analgesic efficacy and sleep quality, and reducing delirium incidence.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (12)
| Peking University First Hospital | Beijing, Beijing Municipality, China | — |
| Xiyuan Hospital of China Academy of Chinese Medical Sciences | Beijing, Beijing Municipality, China | — |
| Peking University International Hospital , , China, Contact: | Beijing, Beijing Municipality, China | — |
| Chongqing University Fuling Hospital | Chongqing, Chongqing Municipality, China | — |
| Guizhou Provincial People's Hospital , China, Contact: | Guiyang, Guizhou, China | — |
| Affiliated Hospital of Hebei University | Baoding, Hebei, China | — |
| The Third Xiangya Hospital of Central South University | Changsha, Hunan, China | — |
| The Second Affiliated Hospital of Air Force Medical University | Xi'an, Shaanxi, China | — |
| Qingdao Municipal Hospital , , China, Contact: | Qingdao, Shandong, China | — |
| Shanxi Provincial Cancer Hospital , China, Contact: | Taiyuan, Shanxi, China | — |
| Tianjin Hospital of ITCWM-Nankai Hospital | Tianjin, Tianjin Municipality, China | — |
| The Third Central Hospital of Tianjin | Tianjin, Tianjin Municipality, China | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03012971